Correspondence
Leukemia (2005) 19, 135. doi:10.1038/sj.leu.2403578 Published online 28 October 2004
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia
P P Piccaluga1, G Martinelli1, M Malagola1, M Rondoni1, F Bonifazi1, G Bandini1, G Visani2 and M Baccarani1
- 1Institute of Haematology and Medical Oncology 'L. & A. Seràgnoli', S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
- 2Department of Hematology, S. Salvatore Hospital, Pesaro, Italy
Correspondence: Dr PP Piccaluga, Institute for Cancer Genetics, Columbia University, 1150 St Nicholas Avenue, Room 307, New York, NY 10032, USA. Fax: +1 212 851 5256; E-mail: ppp2104@columbia.edu
Received 30 August 2004; Accepted 20 September 2004; Published online 28 October 2004.
